BUSINESS OF BIOTECH
Business of Biotech is a lecture and workshop series that introduces grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace.
The series is designed to provide researchers in the life sciences with a comprehensive introduction to the bioscience business environment by exploring the process of transforming a scientific idea into a value-generating product.
Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from: Yale Healthcare & Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion.
YALE INNOVATION SERIES
Yale faculty and researchers are invited to workshops and Q&A sessions with leading experts in the biotech venture capital space who will provide guidance on how to commercialize their technology and attract investment. The series has featured investors from: Canaan Partners, SR One, Venrock, Novartis, Osage University Partners, Abingworth, Sanofi and RA Capital.
Faculty researchers also have the opportunity to pitch to visiting investors.
*Lunch is included.*
Presented by the Office of Cooperative Research.
MARCH 1-MARCH 2, 2017: An intensive, two-day SBIR/STTR workshop focused on proposal development for National Institutes of Health (NIH). Presented by SBIR/STTR expert, Lisa Kurek, the workshop will provide detailed instruction on how to write a competitive proposal that meets the mission and standards of the NIH SBIR/STTR programs.
Attendance at this workshop is the first step in qualifying for the SBIR Accelerate CT program, a CTNext initiative designed to: enhance the competiveness of SBIR/STTR proposals, facilitate collaborations with academia and industry, improve chances of commercialization, and drive economic development. Sponsored by the Office of Cooperative Research, CTNext and Alexion Pharmaceuticals.
YALE INNOVATION SUMMIT
MAY 10, 2017: The Yale Innovation Summit is a day-long event tailored to Yale innovators to encourage the sharing of new discoveries and technologies with market potential with the broader investment community. Last year’s event featured more than 350 attendees including faculty members, local industry executives, students and post-docs. Additionally, over 50 venture capital investors were represented from over 25 firms that in aggregate had over $40 billion under management.
*NEW THIS YEAR: Blavatnik Fund for Innovation at Yale award announcements & Closing remarks by Yale President Peter Salovey
Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute.